GEODE CAPITAL MANAGEMENT, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 215 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.81 and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$66,228,063
+59.2%
2,511,180
+3.8%
0.01%
+60.0%
Q2 2023$41,613,175
+11.4%
2,419,370
+7.4%
0.01%0.0%
Q1 2023$37,357,371
+237210.2%
2,253,158
+9.1%
0.01%
+150.0%
Q4 2022$15,742
-99.9%
2,065,907
+5.2%
0.00%
-33.3%
Q3 2022$19,520,000
+9.1%
1,963,877
-0.3%
0.00%0.0%
Q2 2022$17,891,000
-1.2%
1,970,446
+10.4%
0.00%
+50.0%
Q1 2022$18,113,000
-43.7%
1,784,576
-7.4%
0.00%
-50.0%
Q4 2021$32,149,000
-64.8%
1,927,411
-1.0%
0.00%
-66.7%
Q3 2021$91,259,000
-17.9%
1,947,085
+6.8%
0.01%
-20.0%
Q2 2021$111,187,000
+8.5%
1,823,938
+9.7%
0.02%
-6.2%
Q1 2021$102,438,000
+19.1%
1,662,957
+37.5%
0.02%
+14.3%
Q4 2020$86,023,000
+97.9%
1,209,721
+4.4%
0.01%
+55.6%
Q3 2020$43,472,000
+81.9%
1,158,655
+58.1%
0.01%
+80.0%
Q2 2020$23,901,000
+14.0%
732,935
+1.4%
0.01%0.0%
Q1 2020$20,959,000
-13.9%
722,737
+4.0%
0.01%
+66.7%
Q4 2019$24,350,000
+238.1%
694,756
+107.1%
0.00%
+50.0%
Q3 2019$7,202,000335,4480.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders